Faculty Opinions recommendation of Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1071987.524829 ◽

2007 ◽

Author(s):

Chiara Simonelli

Keyword(s):

Type 1 Diabetes ◽

Pilot Study ◽

Sexual Arousal ◽

Sexual Functioning ◽

Premenopausal Women ◽

Double Blind ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study

Fertility and Sterility ◽

10.1016/j.fertnstert.2005.10.043 ◽

2006 ◽

Vol 85 (5) ◽

pp. 1496-1501 ◽

Cited By ~ 68

Author(s):

Salvatore Caruso ◽

Salvatore Rugolo ◽

Carmela Agnello ◽

Giorgia Intelisano ◽

Lucia Di Mari ◽

...

Keyword(s):

Type 1 Diabetes ◽

Pilot Study ◽

Sexual Arousal ◽

Sexual Functioning ◽

Premenopausal Women ◽

Double Blind ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes mellitus and sexual arousal disorder,

Inpharma Weekly ◽

10.2165/00128413-200615400-00048 ◽

2006 ◽

Vol &NA; (1540) ◽

pp. 17

Author(s):

&NA;

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Sexual Arousal ◽

Sexual Functioning ◽

Premenopausal Women ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study

British Journal of Obstetrics and Gynaecology ◽

10.1016/s0306-5456(00)00143-1 ◽

2001 ◽

Vol 108 (6) ◽

pp. 623-628 ◽

Cited By ~ 48

Author(s):

Salvatore Caruso ◽

Giorgia Intelisano ◽

Lorenzo Lupo ◽

Carmela Agnello

Keyword(s):

Sexual Arousal ◽

Premenopausal Women ◽

Controlled Study ◽

Double Blind ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/j.1471-0528.2001.00143.x ◽

2001 ◽

Vol 108 (6) ◽

pp. 623-628 ◽

Cited By ~ 8

Author(s):

Salvatore Caruso ◽

Giorgia Intelisano ◽

Lorenzo Lupo ◽

Carmela Agnello

Keyword(s):

Sexual Arousal ◽

Premenopausal Women ◽

Controlled Study ◽

Double Blind ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Faculty Opinions recommendation of A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976484.793471199 ◽

2013 ◽

Author(s):

R Taylor Segraves

Keyword(s):

Crossover Trial ◽

Premenopausal Women ◽

Mu Opioid Receptor ◽

Double Blind ◽

Mu Opioid ◽

Double Blind Placebo ◽

High Affinity ◽

Arousal Disorder ◽

Sexual Arousal Disorder ◽

Female Sexual Arousal Disorder

Download Full-text

Enhanced Effects of Specially Formulated Topical Alprostadil Cream by a Continuous Dosing Remedy for the Treatment of Female Sexual Arousal Disorder (FSAD) in a Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial

Fertility and Sterility ◽

10.1016/j.fertnstert.2005.07.321 ◽

2005 ◽

Vol 84 ◽

pp. S131-S132

Author(s):

Q.P. Lao ◽

M. Zhang ◽

J.S. Bai ◽

M.Y. Huang ◽

J. Mo ◽

...

Keyword(s):

Clinical Trial ◽

Sexual Arousal ◽

Controlled Clinical Trial ◽

Double Blind ◽

Female Sexual Arousal ◽

Arousal Disorder ◽

Sexual Arousal Disorder ◽

Female Sexual Arousal Disorder ◽

Continuous Dosing

Download Full-text

ORIGINAL RESEARCH—WOMEN'S SEXUAL HEALTH: An Effect on the Subjective Sexual Response in Premenopausal Women with Sexual Arousal Disorder by Bremelanotide (PT‐141), a Melanocortin Receptor Agonist

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2006.00268.x ◽

2006 ◽

Vol 3 (4) ◽

pp. 628-638 ◽

Cited By ~ 80

Author(s):

Lisa E. Diamond ◽

Dennis C. Earle ◽

Julia R. Heiman ◽

Raymond C. Rosen ◽

Michael. A. Perelman ◽

...

Keyword(s):

Sexual Health ◽

Sexual Arousal ◽

Receptor Agonist ◽

Premenopausal Women ◽

Sexual Response ◽

Melanocortin Receptor ◽

Original Research ◽

Women’S Sexual Health ◽

Arousal Disorder ◽

Sexual Arousal Disorder

Download Full-text

Short‐term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo‐controlled, double blind, cross‐over pilot study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13439 ◽

2018 ◽

Vol 20 (11) ◽

pp. 2685-2689

Author(s):

Andreas Melmer ◽

Patrick Kempf ◽

Lukas Lunger ◽

Thomas R. Pieber ◽

Julia K. Mader ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Sensitivity ◽

Pilot Study ◽

Type 1 Diabetes Mellitus ◽

Postprandial Glucose ◽

Short Term ◽

Double Blind ◽

Postprandial Glucose Excursion

Download Full-text

Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial

Journal of Sex & Marital Therapy ◽

10.1080/00926230390224710 ◽

2003 ◽

Vol 29 (5) ◽

pp. 329-344 ◽

Cited By ~ 26

Author(s):

HARIN PADMA-NATHAN ◽

CANDACE BROWN ◽

JANE FENDL ◽

SHAWKI SALEM ◽

JAMES YEAGER ◽

...

Keyword(s):

Clinical Trial ◽

Sexual Arousal ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Female Sexual Arousal ◽

Arousal Disorder ◽

Sexual Arousal Disorder ◽

Female Sexual Arousal Disorder

Download Full-text

Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Diabetes Care ◽

10.2337/dc13-2955 ◽

2014 ◽

Vol 38 (3) ◽

pp. 412-419 ◽

Cited By ~ 138

Author(s):

Robert R. Henry ◽

Julio Rosenstock ◽

Steven Edelman ◽

Sunder Mudaliar ◽

Alexandros-Georgios Chalamandaris ◽

...

Keyword(s):

Type 1 Diabetes ◽

Pilot Study ◽

Sglt2 Inhibitor ◽

Double Blind ◽

Double Blind Placebo

Download Full-text